Global Anthrax Treatment Market Growth, Share, Size, Trends and Forecast (2023 - 2029)
Segmented by Anthrax Type;
Cutaneous Anthrax, Inhalation Anthrax, Gastrointestinal Anthrax and Injection Anthrax.Segmented by Drug Class;
Antibiotics, Immunoglobulins and Others.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2019 - 2029).Introduction
Global Anthrax Treatment Market (USD Million), 2019 - 2029
# | Global |
---|---|
2019 | 87.2 |
2020 | 102.6 |
2021 | 120.0 |
2022 | 128.5 |
2023 | 136.2 |
2024 | 159.0 |
2025 | 159.1 |
2026 | 189.6 |
2027 | 200.3 |
2028 | 218.3 |
2029 | 259.0 |
In the year 2022, the Global Anthrax Treatment Market was valued at USD 684.98 million. The size of this market is expected to increase to USD 1,252.16 million by the year 2029, while growing at a Compounded Annual Growth Rate (CAGR) of 9.0%.
Global Anthrax Treatment Market Report Snapshot
Parameters | Description |
---|---|
Market | Global Anthrax Treatment Market |
Study Period | 2019 - 2029 |
Base Year (for Anthrax Treatment Market Size Estimates) | 2022 |
Study Scope |
|
Market Segmentation |
|
Geographical Coverage |
|
Company Coverage |
|
Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Anthrax Treatment Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Anthrax Treatment Market Analysis
In this report, the Global Anthrax Treatment Market has been segmented by Anthrax Type, Drug Class and Geography.
Global Anthrax Treatment Market, Segmentation by Anthrax Type
The Global Anthrax Treatment Market has been segmented by Anthrax Type into Cutaneous Anthrax, Inhalation Anthrax, Gastrointestinal Anthrax and Injection Anthrax. The complete Global Anthrax Treatment Market segmentation by Anthrax Type can be seen below:
- Global Anthrax Treatment Market, By Anthrax Type
- Cutaneous Anthrax
- Inhalation Anthrax
- Gastrointestinal Anthrax
- Injection Anthrax
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Anthrax Types mentioned above for historic (2019 - 2022) and forecast (2023 - 2029) periods with 2022 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Anthrax Type is increasing or decreasing with time along with the reasons for changes in the YOY growth with time. The automation in the software industry by product type is a supervisory control and data acquisition (scada), distributed control system (dcs), manufacturing execution systems (mes), human machine interface (hmi), programmable logic controller (plc). The cancer market by cancer type is blood cancer, breast cancer, prostate cancer, gastrointestinal cancer, gynecologic cancer, respiratory/lung cancer, and other cancer types. The functional flour market by type is specialty flour & conventional flour. The plasterboard market by type is damp-proof plasterboard, fire-resistant plasterboard, impact-resistant plasterboard, insulated plasterboard, moisture-resistant plasterboard, sound-insulated plasterboard, standard plasterboard, and thermal plasterboard. The tracheostomy products market by product type is tracheostomy tubes, tracheostomy ventilation accessories, tracheostomy cleaning kits, and other accessories.
Global Anthrax Treatment Market, by Anthrax Type (USD Million), 2019 - 2029
# | Cutaneous Anthrax | Inhalation Anthrax | Gastrointestinal Anthrax | Injection Anthrax |
---|---|---|---|---|
2019 | 63.8 | 62.0 | 65.3 | 55.4 |
2020 | 64.5 | 67.4 | 70.4 | 63.3 |
2021 | 70.1 | 67.5 | 74.5 | 74.9 |
2022 | 83.5 | 69.0 | 78.5 | 82.9 |
2023 | 89.5 | 69.5 | 93.8 | 88.3 |
2024 | 94.8 | 72.4 | 95.8 | 104.5 |
2025 | 96.6 | 80.2 | 104.3 | 105.3 |
2026 | 109.9 | 86.3 | 108.0 | 106.9 |
2027 | 116.0 | 94.4 | 122.5 | 112.5 |
2028 | 129.5 | 102.7 | 124.6 | 114.0 |
2029 | 136.8 | 119.2 | 144.4 | 122.7 |
Global Anthrax Treatment Market, Segmentation by Drug Class
The Global Anthrax Treatment Market has been segmented by Drug Class into Antibiotics, Immunoglobulins and Others. The complete Global Anthrax Treatment Market segmentation by Drug Class can be seen below:
- Global Anthrax Treatment Market, By Drug Class
- Antibiotics
- Immunoglobulins
- Others
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Drug Classs mentioned above for historic (2019 - 2022) and forecast (2023 - 2029) periods with 2022 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Drug Class is increasing or decreasing with time along with the reasons for changes in the YOY growth with time. According to the drug class, by the anthrax treatment guidelines, the prevention of anthrax treatment is done by the anthrax treatment antibiotics and they are antibiotics, immunoglobulins, others. On the basis of drug class, the plaque treatment market can be segmented as tnf-α inhibitors, il-12/23 inhibitors, il-17 inhibitors. Based on the drug, the tularemia market can be divided into streptomycin, gentamycin, doxycycline, ciprofloxacin, and others. The cotton trade market split by application class can be divided into the clothing industry, building industry, transportation, and others. Field programmable gate array (fpga) market by application class is military & aerospace, telecom. The titanium market by application class is aerospace & marine, industrial, medical, energy, pigments, additives & coatings, papers & plastics, others. The life science reagents market by application class is hospitals and diagnostic laboratories, academic and research institutes, and others. The polymer concrete market by application class is asphalt pavement, building, and maintenance, industrial tanks, prefabricated products for drainage systems, and others. The ultrafast laser market by application class is micromachining, bio-imaging, scientific research, medical device fabrication, cardiovascular stent manufacturing, and others. The semiconductor materials market by application class is fabrication and packaging.
Global Anthrax Treatment Market, by Drug Class (USD Million), 2019 - 2029
# | Antibiotics | Immunoglobulins | Others |
---|---|---|---|
2019 | 93.0 | 66.2 | 94.9 |
2020 | 104.9 | 67.9 | 95.7 |
2021 | 112.7 | 72.6 | 105.8 |
2022 | 128.6 | 82.2 | 121.0 |
2023 | 140.5 | 89.4 | 141.6 |
2024 | 158.0 | 106.8 | 142.2 |
2025 | 160.2 | 119.2 | 155.5 |
2026 | 170.5 | 132.4 | 155.6 |
2027 | 172.6 | 150.6 | 176.0 |
2028 | 182.3 | 166.2 | 201.5 |
2029 | 205.9 | 166.5 | 206.7 |
Global Anthrax Treatment Market, Segmentation by Geography
In this report, the Global Anthrax Treatment Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Anthrax Treatment Market Share (%), by Geographical Region, 2022
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Anthrax Treatment Market in all the Regions and Countries (specified above) for historic (2019 - 2022) and forecast (2023 - 2029) Periods with 2022 considered as the base year.
This report also provides an analysis of why the market size of Anthrax Treatment in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Anthrax Treatment Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The growth of the Global Anthrax Treatment Market is driven by; Increase in Research Funding and Development of Novel Therapies for Treatment of Anthrax.
- While the growth of Global Anthrax Treatment Market is currently hindered by; High Cost Associated with Diagnostic Treatment.
- The new opportunities in Global Anthrax Treatment Market will be discussed in detail in the full report.
- Increase in Research Funding.
- Development of Novel Therapies for Treatment of Anthrax.
- High Cost Associated with Diagnostic Treatment.
- Global Anthrax Treatment Market Opportunities will be discussed in detail in the full report.
Market Opportunity Map
This report provides market opportunity map for Anthrax Treatment Market. The opportunity map (by market segments; Anthrax Type and Drug Class) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Anthrax Treatment Market, Opportunity Map, By Region (2019 - 2029)
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Anthrax Treatment Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Anthrax Treatment Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Anthrax Treatment Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Suppliers
Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Anthrax Treatment Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
---|---|---|---|---|
10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Anthrax Treatment Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
---|---|---|---|---|
20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Anthrax Treatment Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
---|---|---|---|---|---|
2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Anthrax Treatment Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
---|---|---|---|---|
5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Anthrax Treatment Market include, Altimune Inc., Elusys Therapeutics, Inc., Emergent BioSolutions, Inc., Porton Biopharma and Pfizer Inc.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
---|---|---|---|---|---|---|---|---|---|---|
Product 1/Service 1 | ||||||||||
Product 2/Service 2 | ||||||||||
Product 3/Service 3 | ||||||||||
Product 4/Service 4 | ||||||||||
Product 5/Service 5 | ||||||||||
Product 6/Service 6 | ||||||||||
Product 7/Service 7 | ||||||||||
Product 8/Service 8 |
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Anthrax Type
- Market Snapshot, By Drug Class
- Market Snapshot, By Region
- Market Opportunity Map
- Global Anthrax Treatment Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increase in Research Funding
- Development of Novel Therapies for Treatment of Anthrax
- Restraints
- High Cost Associated with Diagnostic Treatment
- Opportunities
- Drivers
- Regulatory Scenario
- Reimbursement Scenario
- Mergers & Acquisitions, Collaborations & Partnerships, Agreements
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Anthrax Treatment Market, By Anthrax Type, 2021 - 2031 (USD Million)
- Introduction
- Market Share Analysis, 2023 and 2029 (%)
- Y-o-Y Growth Analysis, 2020 - 2029
- Segment Trends
- Cutaneous Anthrax
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Inhalation Anthrax
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Gastrointestinal Anthrax
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Injection Anthrax
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Cutaneous Anthrax
- Global Anthrax Treatment Market, By Drug Class, 2021 - 2031 (USD Million)
- Introduction
- Market Share Analysis, 2023 and 2029 (%)
- Y-o-Y Growth Analysis, 2020 - 2029
- Segment Trends
- Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Immunoglobulins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019 - 2029 (USD Million)
- Antibiotics
- Global Anthrax Treatment Market, By Geography, 2021 - 2031 (USD Million)
- Introduction
- Market Share Analysis, 2023 and 2029 (%)
- Y-o-Y Growth Analysis, 2020 - 2029
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- Japan
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- Brazil
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Anthrax Type, 2019 - 2029 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2029 (USD Million)
- GCC
- North America
- Global Anthrax Treatment Market, By Anthrax Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Altimune Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Elusys Therapeutics, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Emergent BioSolutions, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Porton Biopharma
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Pfizer Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Altimune Inc.
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2022, the Global Anti Thrombotics Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2029, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2022, the Global Anti-Aging Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2029, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2022, the Global Anti-Asthmatics And COPD Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2029, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2022, the Global Anti Inflammatory Drugs Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2029, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%